NeuroSense Therapeutics
Sharon Cohen-Vered is a VP CMC with extensive experience in the pharmaceutical industry. Sharon has held leadership positions in various companies, including NeuroSense Therapeutics, Raziel Therapeutics, and Neuroderm. With a background in biochemistry, biomedical engineering, and chemical engineering from Tel Aviv University and the Technion - Israel Institute of Technology, Sharon brings a wealth of knowledge and expertise to their roles.
This person is not in any offices
NeuroSense Therapeutics
NeuroSense Therapeutics is a clinical stage drug development company focusing on the development of a ground-breaking treatment for ALS patients, as well as other neurodegenerative diseases.